SXI · Standex International Corp/De/

Grant of Restricted Stock units pursuant to the 2018 Omnibus Incentive Plan of the Company which vests one-third on August 10, 2027, one-third on August 10, 2028, and one-third on August 10, 2029.

Sale of stock pursuant to existing 10b5-1 trading plan dated November 6, 2025.

Award of Restricted Stock Units pursuant to the 2018 Omnibus Incentive Plan of the Company. These shares vest one-third on July 1, 2028 and two-thirds on July 1, 2029.

Sale of stock pursuant to existing 10b5-1 trading plan dated November 6, 2025.

Sale of shares by Donor Advised Fund.

Sale of stock pursuant to existing 10b5-1 trading plan dated November 6, 2025.

Grant of Restricted Stock units pursuant to the 2018 Omnibus Incentive Plan of the Company which vests one-third on May 15, 2027, one-third on May 15, 2028, and one-third on May 15, 2029.

Sale of stock pursuant to existing 10b5-1 trading plan dated November 6, 2025.

Shares forfeited to pay tax liability associated with vesting of previously issued restricted stock.

Shares forfeited to pay tax liability associated with imputed vesting of previously issued restricted stock.

Shares forfeited to pay tax liability associated with vesting of previously issued restricted stock.

Sale of stock pursuant to existing 10b5-1 trading plan dated November 6, 2025.

Sale of stock pursuant to existing 10b5-1 trading plan dated November 6, 2025.

Shares were transferred as a gift with no consideration received.

Sale of stock pursuant to existing 10b5-1 trading plan dated November 12, 2025.

The price reported is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $252.78 to $260.81, inclusive. The reporting person undertakes to provide to the staff of the Securities and Exchange Commission, the Corporation or any security holder of the Corporation, upon request, full information regarding the number of shares sold at each separate price.

Sale of stock pursuant to existing 10b5-1 trading plan dated November 12, 2025.

The price reported is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $252.78 to $260.81, inclusive. The reporting person undertakes to provide to the staff of the Securities and Exchange Commission, the Corporation or any security holder of the Corporation, upon request, full information regarding the number of shares sold at each separate price.

Sale of stock pursuant to existing 10b5-1 trading plan dated November 6, 2025.

Shares previously held by the reporting person directly were transferred into the Cannon Family Trust. .

Shares previously held by the reporting person directly were transferred into the Cannon Family Trust. .

Grant of Restricted Stock units pursuant to the 2018 Omnibus Incentive Plan of the Company which vests one-third on August 23, 2026, one-third on August 23, 2027, and one-third on August 23, 2028.

Award of Performance Share Units pursuant to the 2018 Omnibus Incentive Plan of the Company. These shares cliff vest at the end of a three year performance period with the ultimate number of shares ranging from 0 to 250% of the award based on achievement against Company performance metrics of the three year period.

Grant of Restricted Stock pursuant to the 2018 Omnibus Incentive Plan of the Company which vests one-third per year on each anniversary of the date of the award.

The price reported is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $232.91 to $233.865, inclusive. The reporting person undertakes to provide to the staff of the Securities and Exchange Commission, the Corporation or any security holder of the Corporation, upon request, full information regarding the number of shares sold at each separate price.

The price reported is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $229.66 to $230.23, inclusive. The reporting person undertakes to provide to the staff of the Securities and Exchange Commission, the Corporation or any security holder of the Corporation, upon request, full information regarding the number of shares sold at each separate price.

Shares forfeited to pay tax liability associated with imputed vesting of previously issued restricted stock.

Vesting of Phantom Stock pursuant to the terms of the underlying awards due to the reporting person's retirement as a Director of the Company.

Grant of Restricted Stock pursuant to the Company's 2018 Omnibus Incentive Plan that vests three years after the date of grant.

Grant of Restricted Stock pursuant to the Company's 2018 Omnibus Incentive Plan that vests three years after the date of grant.

Vesting of Phantom Stock pursuant to the terms of the underlying awards due to the reporting person's retirement as a Director of the Company.

Vesting of Phantom Stock pursuant to the terms of the underlying awards due to the reporting person's retirement as a Director of the Company.

Vesting of Phantom Stock pursuant to the terms of the underlying awards due to the reporting person's retirement as a Director of the Company.

Grant of Restricted Stock pursuant to the Company's 2018 Incentive Plan that vests three years after the date of grant.

Vesting of Phantom Stock pursuant to the terms of the underlying awards due to the reporting person's retirement as a Director of the Company.

Grant of Restricted Stock pursuant to the Company's 2018 Omnibus Incentive Plan that vests three years after the date of grant.

Vesting of Phantom Stock pursuant to the terms of the underlying awards due to the reporting person's retirement as a Director of the Company.

Grant of Restricted Stock pursuant to the Company's 2018 Omnibus Incentive Plan that vests three years after the date of grant.

Grant of Restricted Stock pursuant to the Company's 2018 Omnibus Incentive Plan that vests three years after the date of grant.

Grant of Restricted Stock pursuant to the Company's 2018 Omnibus Incentive Plan that vests three years after the date of grant.

Sale of stock pursuant to existing 10b5-1 trading plan dated November 22, 2024.

Sale of stock pursuant to existing 10b5-1 trading plan dated November 22, 2024.

Represents acquisition of stock pursuant to the Company's Employee Stock Purchase Plan.

Sale of stock pursuant to existing 10b5-1 trading plan dated November 22, 2024.